[HTML][HTML] A review on therapeutic drug monitoring of immunosuppressant drugs
Immunosuppressants require therapeutic drug monitoring because of their narrow
therapeutic index and significant inter-individual variability in blood concentrations. This …
therapeutic index and significant inter-individual variability in blood concentrations. This …
A systematic Review of multiple linear regression-based limited sampling strategies for mycophenolic acid area under the concentration–time curve estimation
J Sobiak, M Resztak - European Journal of Drug Metabolism and …, 2021 - Springer
Abstract Background and Objective One approach of therapeutic drug monitoring in the case
of mycophenolic acid (MPA) is a limited sampling strategy (LSS), which allows the …
of mycophenolic acid (MPA) is a limited sampling strategy (LSS), which allows the …
The development of a population physiologically based pharmacokinetic model for mycophenolic mofetil and mycophenolic acid in humans using data from plasma …
MM Alsmadi, MQ Alfarah, J Albderat… - … & Drug Disposition, 2019 - Wiley Online Library
Background Mycophenolic acid (MPA) is used widely to prevent graft rejection in kidney‐
transplant patients. Therapeutic drug monitoring (TDM) in plasma requires an invasive …
transplant patients. Therapeutic drug monitoring (TDM) in plasma requires an invasive …
A prospective analysis of the effects of enteric-coated mycophenolate sodium and mycophenolate mofetil co-medicated with a proton pump inhibitor in kidney …
L Xu, M Cai, BY Shi, ZL Li, X Li, HL ** - Transplantation Proceedings, 2014 - Elsevier
Background Enteric-coated mycophenolate sodium (EC-MPS) and mycophenolate mofetil
(MMF), two prodrugs of mycophenolic acid (MPA), have been used in immunosuppressive …
(MMF), two prodrugs of mycophenolic acid (MPA), have been used in immunosuppressive …
Evalutation of mycophenolic acid systemic exposure by limited sampling strategy in kidney transplant recipients receiving enteric-coated mycophenolate sodium (EC …
D Capone, G Tarantino, I Kadilli… - Nephrology Dialysis …, 2011 - academic.oup.com
Background. Enteric-coated mycophenolate sodium (EC-MPS) and mycophenolate mofetil
(MMF) are prodrugs of mycophenolic acid (MPA). Although many patients still receive MMF …
(MMF) are prodrugs of mycophenolic acid (MPA). Although many patients still receive MMF …
Limited sampling strategies for mycophenolic acid in solid organ transplantation: a systematic review
NK Bruchet, MHH Ensom - Expert opinion on drug metabolism & …, 2009 - Taylor & Francis
Background: Mycophenolic acid (MPA) is the active metabolite of mycophenolate mofetil, a
widely used immunosuppressant. Numerous studies have developed limited sampling …
widely used immunosuppressant. Numerous studies have developed limited sampling …
Therapeutic drug monitoring of mycophenolate mofetil and enteric-coated mycophenolate sodium in patients with systemic lupus erythematosus
S Djabarouti, P Duffau, E Lazaro… - Expert opinion on …, 2010 - Taylor & Francis
Objective: Mycophenolic acid (MPA), the active form of mycophenolate mofetil (MMF) and
enteric-coated mycophenolate sodium (EC-MPS), is used to treat systemic lupus …
enteric-coated mycophenolate sodium (EC-MPS), is used to treat systemic lupus …
Limited sampling strategies for predicting area under the concentration-time curve of mycophenolic acid in islet transplant recipients
M Al-Khatib, RJ Shapiro, N Partovi… - Annals of …, 2010 - journals.sagepub.com
BACKGROUND Mycophenolate mofetil is widely used in islet transplant recipients and its
active metabolite, mycophenolic acid (MPA), exhibits wide pharmacokinetic variability …
active metabolite, mycophenolic acid (MPA), exhibits wide pharmacokinetic variability …
[HTML][HTML] Nonlinear relationship between enteric-coated mycophenolate sodium dose and mycophenolic acid exposure in Han kidney transplantation recipients
J Zhang, M Jia, L Zuo, N Li, Y Luo, Z Sun… - … Pharmaceutica Sinica B, 2017 - Elsevier
The aim of the research was to investigate the pharmacokinetics (PK) of enteric-coated
mycophenolate sodium (EC-MPS) by quantification of the active metabolite of mycophenolic …
mycophenolate sodium (EC-MPS) by quantification of the active metabolite of mycophenolic …
[PDF][PDF] Mycophenolic Acid pharmacokinetics early after kidney transplant
N Honarbakhsh, MR Rouini, M Lesan-Pezeshki… - Exp Clin …, 2013 - academia.edu
Objectives: To determine the mycophenolic acid pharmacokinetic profile early after
transplant in Iranian kidney graft recipients. Materials and Methods: A cross-sectional study …
transplant in Iranian kidney graft recipients. Materials and Methods: A cross-sectional study …